Stefania Cuzzubbo
Université Paris Cité(FR)Sorbonne Paris Cité(FR)Assistance Publique – Hôpitaux de Paris(FR)Assistance Publique – Hôpitaux de Paris(FR)Hôpital Saint-Louis(FR)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Brain Metastases and Treatment
Most-Cited Works
- → Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature(2017)534 cited
- → Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM)(2021)261 cited
- → Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments(2021)123 cited
- → Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment(2020)119 cited
- → APR-246 Combined with Azacitidine (AZA) in TP53 Mutated Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML). a Phase 2 Study By the Groupe Francophone Des Myélodysplasies (GFM)(2019)65 cited
- → Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8 + T cell activation in the presence of adjuvant temozolomide